{"rows":[{"id":2290,"title":"Natural Psychoplastogens As Antidepressant Agents.","authors":"Benko J, Vranková S","journal":"Molecules (Basel, Switzerland)","publication_date":"2020-03-05","publication_year":2020,"doi":"10.3390/molecules25051172","pubmed_id":"32150976","openalex_id":"https://openalex.org/W3010070566","source_url":"https://pubmed.ncbi.nlm.nih.gov/32150976/","substance_tags":"psilocybin","topic_tags":"Depression,Pharmacology,Mechanism of Action,Adverse Events","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:24","bibtex":null,"source_record_id":"PMID:32150976","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/32150976/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:32150976","source_url":"https://pubmed.ncbi.nlm.nih.gov/32150976/","doi":"10.3390/molecules25051172","pmid":"32150976","publication_date":"2020-03-05","importer_version":"2.1.3","text_redistributed":false}},{"id":2163,"title":"Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans.","authors":"Cumming P, Scheidegger M, Dornbierer D, Palner M, Quednow BB, Martin-Soelch C","journal":"Molecules (Basel, Switzerland)","publication_date":"2021-04-22","publication_year":2021,"doi":"10.3390/molecules26092451","pubmed_id":"33922330","openalex_id":"https://openalex.org/W3153638782","source_url":"https://pubmed.ncbi.nlm.nih.gov/33922330/","substance_tags":"psilocybin,psilocin","topic_tags":"Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Emotional Processing,Review Article,In Vitro Study,Drug Interactions","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:22","bibtex":null,"source_record_id":"PMID:33922330","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/33922330/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:33922330","source_url":"https://pubmed.ncbi.nlm.nih.gov/33922330/","doi":"10.3390/molecules26092451","pmid":"33922330","publication_date":"2021-04-22","importer_version":"2.1.3","text_redistributed":false}},{"id":2152,"title":"The Therapeutic Potential of Psilocybin.","authors":"Lowe H, Toyang N, Steele B, Valentine H, Grant J, Ali A, Ngwa W, Gordon L","journal":"Molecules (Basel, Switzerland)","publication_date":"2021-05-15","publication_year":2021,"doi":"10.3390/molecules26102948","pubmed_id":"34063505","openalex_id":"https://openalex.org/W3161556967","source_url":"https://pubmed.ncbi.nlm.nih.gov/34063505/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Addiction,Pharmacology,Spirituality,Systematic Review,Review Article","study_type":"Systematic Review","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:22","bibtex":null,"source_record_id":"PMID:34063505","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/34063505/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:34063505","source_url":"https://pubmed.ncbi.nlm.nih.gov/34063505/","doi":"10.3390/molecules26102948","pmid":"34063505","publication_date":"2021-05-15","importer_version":"2.1.3","text_redistributed":false}},{"id":1795,"title":"Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.","authors":"Lowe H, Toyang N, Steele B, Grant J, Ali A, Gordon L, Ngwa W","journal":"Molecules (Basel, Switzerland)","publication_date":"2022-04-14","publication_year":2022,"doi":"10.3390/molecules27082520","pubmed_id":"35458717","openalex_id":"https://openalex.org/W4224106670","source_url":"https://pubmed.ncbi.nlm.nih.gov/35458717/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Addiction,Pharmacology,Spirituality,Review Article,Cancer Patients,Adverse Events,Toxicity","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:20","bibtex":null,"source_record_id":"PMID:35458717","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/35458717/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:35458717","source_url":"https://pubmed.ncbi.nlm.nih.gov/35458717/","doi":"10.3390/molecules27082520","pmid":"35458717","publication_date":"2022-04-14","importer_version":"2.1.3","text_redistributed":false}},{"id":1665,"title":"Chinese Cordyceps: Bioactive Components, Antitumor Effects and Underlying Mechanism-A Review.","authors":"Liu Y, Guo ZJ, Zhou XW","journal":"Molecules (Basel, Switzerland)","publication_date":"2022-10-03","publication_year":2022,"doi":"10.3390/molecules27196576","pubmed_id":"36235111","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/36235111/","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Review Article,Immune Function","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-07-01 06:54:13","bibtex":null,"source_record_id":"PMID:36235111","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/36235111/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:36235111","source_url":"https://pubmed.ncbi.nlm.nih.gov/36235111/","doi":"10.3390/molecules27196576","pmid":"36235111","publication_date":"2022-10-03","importer_version":"2.1.3","text_redistributed":false}},{"id":1531,"title":"The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice.","authors":"Zanikov T, Gerasymchuk M, Ghasemi Gojani E, Robinson GI, Asghari S, Groves A, Haselhorst L, Nandakumar S, Stahl C, Cameron M, Li D, Rodriguez-Juarez R, Snelling A, Hudson D, Fiselier A, Kovalchuk O, Kovalchuk I","journal":"Molecules (Basel, Switzerland)","publication_date":"2023-03-14","publication_year":2023,"doi":"10.3390/molecules28062624","pubmed_id":"36985596","openalex_id":"https://openalex.org/W4324147331","source_url":"https://pubmed.ncbi.nlm.nih.gov/36985596/","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Mechanism of Action,Biomarkers,Animal Study,Inflammation","study_type":"Animal Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:16","bibtex":null,"source_record_id":"PMID:36985596","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/36985596/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:36985596","source_url":"https://pubmed.ncbi.nlm.nih.gov/36985596/","doi":"10.3390/molecules28062624","pmid":"36985596","publication_date":"2023-03-14","importer_version":"2.1.3","text_redistributed":false}}],"total":6,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Molecules (Basel, Switzerland)","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}